Adam David Sachs Sells 13,754 Shares of Vicarious Surgical Inc (NYSE:RBOT) Stock

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 13,754 shares of Vicarious Surgical stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $0.97, for a total transaction of $13,341.38. Following the transaction, the chief executive officer now directly owns 1,783,514 shares in the company, valued at $1,730,008.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Adam David Sachs also recently made the following trade(s):

• On Monday, August 21st, Adam David Sachs sold 24,251 shares of Vicarious Surgical stock. The shares were sold at an average price of $0.91, for a total transaction of $22,068.41.
• On Tuesday, June 20th, Adam David Sachs sold 4,142 shares of Vicarious Surgical stock. The shares were sold at an average price of $2.05, for a total transaction of $8,491.10.

Vicarious Surgical Price Performance

NYSE:RBOT opened at $0.95 on Friday. The business’s 50-day moving average is $1.36 and its two-hundred day moving average is $1.92. Vicarious Surgical Inc has a 12 month low of $0.82 and a 12 month high of $4.57.

Vicarious Surgical (NYSE:RBOT) last announced its earnings results on Thursday, July 27th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.03). As a group, equities research analysts predict that Vicarious Surgical Inc will post -0.63 EPS for the current year.

Institutional Trading of Vicarious Surgical

Hedge funds have recently made changes to their positions in the company. J.W. Cole Advisors Inc. purchased a new position in shares of Vicarious Surgical in the first quarter valued at $28,000. Barclays PLC grew its stake in shares of Vicarious Surgical by 541.6% during the fourth quarter. Barclays PLC now owns 14,840 shares of the company’s stock valued at $30,000 after acquiring an additional 12,527 shares in the last quarter. Bank of Montreal Can purchased a new stake in shares of Vicarious Surgical during the second quarter worth about $33,000. Verition Fund Management LLC purchased a new stake in shares of Vicarious Surgical during the second quarter worth about $36,000. Finally, Citigroup Inc. lifted its stake in shares of Vicarious Surgical by 1,758.2% in the second quarter. Citigroup Inc. now owns 20,868 shares of the company’s stock worth $38,000 after acquiring an additional 19,745 shares in the last quarter. Hedge funds and other institutional investors own 65.16% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.